{
  "report_rows": [
    {
      "kpi": "Q2 non-GAAP EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$0.88 vs. cons $0.87",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.85B vs. cons ~$2.88B",
      "confidence": "LOW"
    },
    {
      "kpi": "Q2 GAAP EPS (incl. ~$0.31 Aquarion loss-on-sale charge)",
      "prediction": "MISS",
      "answer": "pred ~$0.56 vs. cons ~$0.62",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 non-GAAP EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$4.65 (range $4.57-$4.72) vs. cons $4.66 (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Long-term EPS CAGR (off $4.65 base)",
      "prediction": "UNCHANGED",
      "answer": "guide ~5-7% (upper-half by 2028) vs. Street ~6% (2025-2029)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FERC transmission Section 205 ROE path",
      "prediction": "UNKNOWN",
      "answer": "guide ~11.39% target vs. current 9.57% base (effective 2H26, subject to refund)",
      "confidence": "LOW"
    },
    {
      "kpi": "CL&P rate case ask / affordability tone",
      "prediction": "UNKNOWN",
      "answer": "guide ~$727M (~18% res. bill) vs. no cons est. (decision 2027)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -0.6,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -1.3,
  "day5_path": "FADE",
  "day5_rationale": "In-line EPS and a twice-reset guide reaffirmed at $4.65 midpoint offer no upside revision catalyst, while the stock sits near 52-week highs (+10% YTD, well ahead of XLU) with the de-risking thesis largely priced. No out-period estimate raise, ongoing FERC retroactive-refund overhang, and politically charged CL&P rate case tone bias post-print revisions/positioning modestly lower, so an initial flat-to-down reaction fades further.",
  "day5_confidence": "LOW"
}